Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes sir - have a nice paycheck coming Friday so you know where some of that is going!
Yep - still think these prices are long gone after this week.
Keep shorting - PLEASE!!!
Very very excellent. U get my PM?
Looks that way. Great to see.
Have a feeling this is the last week to load this cheap - forever!
Another 100K buy - ready to head back up now - loading more for the real run!
Adding more!
So much going on behind the scenes. All will be revealed soon.
Agree. Nice day today. Looks like bottom is in. Next updates will take us to the next level and beyond imo.
LOL - Very, very, very screwed.
Thanks,
No notes, no insider sales, OTCN going to get killed here!!!
Have a feeling all of us will be very surprised in a very good way very soon. Using lots of very's in my last 2 posts - lol
Nice buys this morning - OTCN 100% shorting here - will get burned very badly very, very, very soon!!!
Agree
Don't need to hope
Stock price may be discouraging currently but nothing has changed with the company except that it is stronger then ever. There may be a very good reason for the recent silence and I would expect all to be revealed soon.
Absolute moron!!!
I think I may have a few.
Love the quietness. Everyone who knows anything is just long and holding. Things are said when they need to be.
Just added as well and have more powder - what a gift!
Someone must need cash very badly and the MM's having a field day with them.
Will go right back up as always. Looking for news to take this to the next level at anytime now.
No worries at all on the low volume walkdown. Shitty, slow market right now all over.
Just a very bad time to need money!
Nice. Post it everywhere to get the word out. Great article.
XCRT - great article just out -
https://otcstockz.com/otc-stocks/in-the-world-of-penny-stocks-keep-an-eye-on-xcelerate-inc-otcmkts-xcrt-stock-as-a-leading-healthcare-services-stock-in-2023/
In the world of penny stocks, keep an eye on Xcelerate, Inc. (OTCMKTS: XCRT Stock) as a leading Healthcare Services stock in 2023.
Summary
Since March 2021, under the dynamic leadership of CEO and Director Mike O’Shea, Xcelerate Inc (OTCQB:XCRT) has achieved significant milestones. These accomplishments have driven the company’s progression from Shell status to Pink Current, and subsequently to its current OTCQB status with a future plan of uplisting to the New York Stock Exchange.(As stated in public interviews)
Xcelerate has acquired a collection of licensed and patented intellectual property. As per their latest announcement, the company has substantially expanded its patent portfolio, securing patent rights in nine more countries, which now includes the EU, Russia, and Korea.
Xcelerate has achieved noteworthy accomplishments, such as acquiring a 51% membership interest in AfiyaSasa Africa, LLC, and initiating the AfiyaSasa Africa Pilot Project in hospitals across Africa.
Recently, Xcelerate, Inc. concluded the acquisition of a majority interest in ESN Group, Inc. and California Skin Research, Inc. (collectively referred to as the “ESN Group”). This acquisition encompasses a diverse portfolio of healthcare and skincare products, including the innovative Ceramedx® (www.ceramedx.com), the first natural plant-based ceramide therapy system designed in consultation with dermatologists for dry, sensitive skin, as well as Earth Science Beauty (www.earthsciencebeauty.com).
About Xcelerate Inc (OTC: XCRT stock).: Pioneering the Future of Healthcare Through Innovation
In the ever-changing landscape of healthcare, there are companies that stand out not only for their vision, but also for their immense impact. Xcelerate Inc. is certainly one such company, positioned to change the medical, health, and wellness industries with a visionary business plan that covers three unique yet intertwined branches.
Driven by a strong dedication to improving healthcare, Xcelerate is on a mission that impacts people worldwide. Their unique approach involves three core businesses – medical, health and wellness, each designed to address crucial aspects of healthcare in innovative and unprecedented ways:
1. Empowering Medical Technology: A World of Possibilities
Xcelerate’s first venture revolves around the ownership and licensing of a diverse range of medical equipment, coupled with an extensive portfolio of patents, pending patents, and technology licenses. This effort makes Xcelerate a leader in medical progress, making sure that the newest and most important discoveries are used to their maximum potential, benefiting both patients and medical professionals.
2. Bridging Healthcare Gaps: Virtual Health for All
Perhaps the most ambitious of their endeavors, Xcelerate is committed to bridging the healthcare gap in developing countries, with an initial focus on Africa. Through the development of virtual health technology, the company aims to extend the reach of physicians and provide accessible medical care to underserved populations. This creative method demonstrates how Xcelerate is committed to using technology to make sure everyone around the world has the same chance for good health.
3. Beauty and Science Converge: Redefining Skincare
The company’s third endeavor focuses on the formulation, packaging, and marketing of clinically tested, over-the-counter skin care products. These products have been tested clinically to make sure they work effectively. This careful combination of science and artistic design highlights how Xcelerate is dedicated to taking care of overall well-being.
A Synergy of Expertise: The Xcelerate Management Advantage
Xcelerate’s success lies in a globally renowned team consisting of translational clinicians and engineers. Instead of concentrating solely on development, the company strategically identifies and acquires cutting-edge healthcare technologies. This strategy, according to Xcelerate, leads to reduced expenses in product development and marketing, while also enabling faster integration into clinical practices and swifter attainment of profitability and return on investment.
In the driver’s seat of Xcelerate, you’ll find an exceptional management team with a wealth of experience and diverse expertise. Leading the pack is CEO and Director Mike O’Shea, a certified financial investigator and forensic accountant, who possesses a wealth of experience from his involvement with organizations like the US Secret Service, ATF, and other distinguished institutions. His extensive background emphasizes his in-depth comprehension of complex financial intricacies.
Joining the team as Director is Jason Householder, who also serves as the Co-Founder and CEO of Charlotte’s LenDRgroup Consulting. With over a decade devoted to healthcare banking, Jason specializes in crafting effective strategies for medical, dental, and veterinary practices. His insights help these practices navigate the complexities of business operations seamlessly.
Steve Gravely, presently the President of the Consulting Group at Jocassee, Inc., contributes significantly to the leadership. His remarkable track record includes spearheading 25 global manufacturing plants and overseeing the successful launch of over 300 new products for prominent industry giants like Michelin, AT&T, NCR, and General Motors. His expertise adds a distinctive dimension to the already extensive skill set of the management team.
Adding to this exceptional ensemble is Jon Wilken, he is a 30-year veteran of the retail food industry. He is the former President and CEO of BILO Inc., a supermarket chain which at the time of his employment was wholly owned by Ahold NV of The Netherlands. While Jon was at BILO, the company employed approximately 26,000 associates and operated over 400 retail supermarkets and convenience stores in four Southeastern States with annual sales of approximately $4.0 Billion. Since leaving Ahold/BILO in 2002 Jon has pursued entrepreneurial business ventures including partnering in a 250+ acre commercial and retail real estate planned development, The Point, in Greenville, South Carolina. The project to date has a Whole Foods supermarket, a retail shopping center, several restaurants, over 500 apartments, 8 hotels, and a 40-acre TD Bank call center campus.
Distinguished Advisory Board Members
Within Xcelerate Inc., an esteemed advisory board boasts the presence of eminent figures such as Dr. Barry Marshall, a distinguished Nobel laureate in the medical field. Alongside him stands the renowned neurosurgeon Dr. Dilan B. Ellegala, adding further depth to the board’s expertise. Also lending their insights is Dr. Anja Glisovic, a research scholar with a PhD in X Ray & Material Physics, contributing a unique perspective to the team.
In a recent addition, the advisory board extended a warm welcome to Cathy Scangarella, who currently holds the position of Chief Business Development Officer and Sector Lead for the Life Sciences at Choose New Jersey. With her involvement, the board continues to amass a wealth of industry knowledge, fortifying Xcelerate’s commitment to pioneering advancements in healthcare.
Current Ventures: Navigating Healthcare’s Frontier
Embarking on a journey through the forefront of healthcare innovation, Xcelerate Inc. is shaping the future with its dynamic and multi-faceted approach. Starting from acquiring a collection of licensed and patented intellectual property, the company’s current ventures span a diverse spectrum of groundbreaking initiatives in the medical, health, and wellness sectors.
1) Inventory of Patents Under Xcelerate Inc. Ownership and Acquisition.:
The collection includes four approved and one awaiting U.S. patents, along with two approved and one pending European patent. Additionally, the portfolio encompasses specific licensing agreements linked to research advancements from Cambridge University.
U.S. 9,889,151: Techniques for treating certain cancers using a composition that releases orthosilicic acid in the body.
U.S. 9,333,224: Methods for treating bacterial infections with a composition that releases orthosilicic acid in the body.
U.S. 10,493,097: Approaches for treating specific ulcer types (wounds) with a composition that releases orthosilicic acid in the body.
U.S. 16/089,613: Composition for bone repair or replacement containing silicate and bone/bone surrogate.
U.S. 16/670,060 (pending): Pending
EP 2211868: Silicate solution for treating melanoma
EP 3305305: Silicate solution for wound healing
EP 211782776 pending
In-licensed IP ((UK research and innovation)
Granted US, EP, AU, JP, Eurasian, CN patents in CA, HK, KR, SG
2) Development of virtual health technology to assist patients in developing countries:
Xcelerate has a strong dedication to closing the healthcare gap in developing countries, starting with a special focus on Africa. By creating virtual health technology, the company aims to make it possible for doctors to reach more people and offer medical care to those who currently have limited access.
To make this possible, Xcelerate has secured a 51% ownership in a startup medical technology and virtual health company AfiyaSasa Africa, LLC (ASA), initiated by the globally recognized Tanzanian Neurosurgeon, Dilan Ellegala. Company helps patients in developing countries talk to doctors through its platform to get the medical care they need. The ASA platform uses smart technology like AI (artificial intelligence) and AR (Augmented Reality), created by AdviNOW. This helps people who live far away from medical help and don’t have many doctors nearby, whether they’re in remote places or cities.Patients can use their cell phones, tablets, or computers to use the system. It lets doctors and medical staff assess their condition, decide the best care, and guide them through the process online. The system even has facial recognition and can remember if the patient has used it before.
The AfiyaSasa Tanzania Project is getting ready to start in various hospitals across the country with the help of its own subsidiary. Each hospital will provide special services and telehealth features as part of this project.
Back in March 2023, Xcelerate took a big step by signing an Agreement to bring its Artificial Intelligence (AI) based health services to The National Hospital of Tanzania, Muhimbili National Hospital, and Mloganzila in Dar es Salaam. This is the largest hospital in East Africa. The Muhimbili National Hospital System is the premier tertiary care hospital system for all of Tanzania, a country with 64 million people. It has around 1,500 beds for patients and serves about 2,000 patients every day.
Just two weeks later, Xcelerate signed another Agreement to introduce its AI-based health services to Haydom Regional Rural Referral Hospital, which is also known as Haydom Lutheran Hospital (“HLH”), in Haydom, Tanzania. HLH is a big hospital with 420 beds and it takes care of 5.7 million people in North Central Tanzania. Every year, HLH helps around 12,635 patients who stay in the hospital and supports about 103,173 patients who visit for outpatient care.
And there’s more to come – two more hospitals will be joining this important project soon.
3) Acquisition of Healthcare and Skincare Companies:
Xcelerate has initiated the establishment of its Xcelerate Brands division. The core objective of this division is to collaborate with marketing and manufacturing partners, working together to create over-the-counter healthcare products. These products draw from both Xcelerate’s existing patent portfolio and those of strategic partners.
In a recent development, Xcelerate, Inc. has successfully acquired a significant stake in ESN Group, Inc. and California Skin Research, Inc., collectively known as the “ESN Group.” This strategic move brings under Xcelerate’s umbrella a wide-ranging array of healthcare and skincare products. The acquisition encompasses the innovative Ceramedx® (www.ceramedx.com), a revolutionary plant-based ceramide therapy system specifically developed in consultation with dermatologists to address the concerns of individuals with dry and sensitive skin. Additionally, Xcelerate gains access to the offerings of Earth Science Beauty, further enhancing their portfolio of innovative skincare solutions.
Earth Science Naturals (ESN Group, Inc.), headquartered in Santa Barbara, California, is a passionate advocate for delivering natural beauty products that are both sustainable and cruelty-free. The foundation of ESN Group lies in crafting effective, clean skincare formulations derived from the Earth’s natural botanicals. ESN group claims to offer one of the most extensive ranges of fragrance-free beauty products available today. They meticulously source the purest ingredients, ensuring the utmost efficacy and top-quality outcomes.
Presently, ESN Group, Inc. manages two operational businesses generating revenue, which include:
Ceramedx, a facial cleanser specially formulated for dry, sensitive skin, features ESN’s exclusive RiceramideTR-3. This innovative product harnesses ESN’s natural ceramide technology. (www.ceramedx.com)
Earth Science Beauty (www.earthsciencebeauty.com) provides a range of plant-based solutions designed for skin, body, and hair care needs.
In addition to this acquisition, Xcelerate also entered into a strategic marketing agreement with ProductSector, LLC and its collaborator company, CCI Vegas. This company is an expert in brand development, particularly within the health and wellness sector. They have been working together with the management team from ESN to expand mass merchant outlets and government agencies.
Strategic Future Plans
These future plans are a testament to Xcelerate’s unwavering dedication to advancing healthcare on multiple fronts. The company’s vision extends beyond the present, encompassing breakthroughs in medical technology, virtual health solutions, and even skincare innovations. By embracing the power of technology and collaboration, Xcelerate aims to address critical healthcare challenges, bridge gaps in medical access, and provide solutions that cater to both physical well-being and self-care. Through these strategic endeavors, Xcelerate is poised to shape a more inclusive and progressive future for healthcare.Xcelerate’s plans go beyond just changing healthcare – they could also lead to more earnings. By offering a mix of medical technology, virtual health, and skincare products, the company is setting itself up to make money from different sources. This smart approach could help Xcelerate grow financially while also making a positive impact on healthcare overall.One of the notable aspects of Xcelerate’s journey is its plan for uplisting to the Nasdaq. The company’s progression from being a Pink Current to OTCQB-listed entity reflects its commitment to transparency and growth. A potential uplisting could offer greater visibility, credibility, and access to a broader investor base. This transition will undoubtedly be closely monitored by investors and market analysts for its implications on the company’s valuation and future prospects.
Corporate Information
Xcelerate holds OTCQB status as indicated on otcmarkets.com under the symbol XCRT.
As of August 15th, 2023, Xcelerate, Inc. presents a well-defined share structure that sheds light on its market dynamics. The company’s authorized shares total 1,000,000,000, while the outstanding shares in circulation amount to 406,446,072. Among these, a float of 113,254,437 shares is available for trading on the market, with the remaining 269,291,635 shares designated as restricted. Company holds a market capitalization of $33,328,578 as of August 15th, 2023
Conclusion
In the world of penny stocks, Xcelerate, Inc. (OTC: XCRT) has emerged as a standout Healthcare Services stock in 2023. Under the leadership of CEO and Director Mike O’Shea, the company has achieved remarkable progress, transitioning from its initial shell status to Pink Current and eventually reaching the esteemed OTCQB tier with ambitions of listing on the New York Stock Exchange. Xcelerate’s diverse initiatives, spanning innovative medical technology, virtual health solutions, and skincare innovations, show a holistic approach to improving healthcare. With a skilled team and strategic partnerships, the company aims not only for financial growth but also to create a positive impact on healthcare. The potential move to the NYSE adds another layer of interest, hinting at exciting times ahead for investors and the industry as a whole.
XCRT - great article just out -
https://otcstockz.com/otc-stocks/in-the-world-of-penny-stocks-keep-an-eye-on-xcelerate-inc-otcmkts-xcrt-stock-as-a-leading-healthcare-services-stock-in-2023/
In the world of penny stocks, keep an eye on Xcelerate, Inc. (OTCMKTS: XCRT Stock) as a leading Healthcare Services stock in 2023.
Summary
Since March 2021, under the dynamic leadership of CEO and Director Mike O’Shea, Xcelerate Inc (OTCQB:XCRT) has achieved significant milestones. These accomplishments have driven the company’s progression from Shell status to Pink Current, and subsequently to its current OTCQB status with a future plan of uplisting to the New York Stock Exchange.(As stated in public interviews)
Xcelerate has acquired a collection of licensed and patented intellectual property. As per their latest announcement, the company has substantially expanded its patent portfolio, securing patent rights in nine more countries, which now includes the EU, Russia, and Korea.
Xcelerate has achieved noteworthy accomplishments, such as acquiring a 51% membership interest in AfiyaSasa Africa, LLC, and initiating the AfiyaSasa Africa Pilot Project in hospitals across Africa.
Recently, Xcelerate, Inc. concluded the acquisition of a majority interest in ESN Group, Inc. and California Skin Research, Inc. (collectively referred to as the “ESN Group”). This acquisition encompasses a diverse portfolio of healthcare and skincare products, including the innovative Ceramedx® (www.ceramedx.com), the first natural plant-based ceramide therapy system designed in consultation with dermatologists for dry, sensitive skin, as well as Earth Science Beauty (www.earthsciencebeauty.com).
About Xcelerate Inc (OTC: XCRT stock).: Pioneering the Future of Healthcare Through Innovation
In the ever-changing landscape of healthcare, there are companies that stand out not only for their vision, but also for their immense impact. Xcelerate Inc. is certainly one such company, positioned to change the medical, health, and wellness industries with a visionary business plan that covers three unique yet intertwined branches.
Driven by a strong dedication to improving healthcare, Xcelerate is on a mission that impacts people worldwide. Their unique approach involves three core businesses – medical, health and wellness, each designed to address crucial aspects of healthcare in innovative and unprecedented ways:
1. Empowering Medical Technology: A World of Possibilities
Xcelerate’s first venture revolves around the ownership and licensing of a diverse range of medical equipment, coupled with an extensive portfolio of patents, pending patents, and technology licenses. This effort makes Xcelerate a leader in medical progress, making sure that the newest and most important discoveries are used to their maximum potential, benefiting both patients and medical professionals.
2. Bridging Healthcare Gaps: Virtual Health for All
Perhaps the most ambitious of their endeavors, Xcelerate is committed to bridging the healthcare gap in developing countries, with an initial focus on Africa. Through the development of virtual health technology, the company aims to extend the reach of physicians and provide accessible medical care to underserved populations. This creative method demonstrates how Xcelerate is committed to using technology to make sure everyone around the world has the same chance for good health.
3. Beauty and Science Converge: Redefining Skincare
The company’s third endeavor focuses on the formulation, packaging, and marketing of clinically tested, over-the-counter skin care products. These products have been tested clinically to make sure they work effectively. This careful combination of science and artistic design highlights how Xcelerate is dedicated to taking care of overall well-being.
A Synergy of Expertise: The Xcelerate Management Advantage
Xcelerate’s success lies in a globally renowned team consisting of translational clinicians and engineers. Instead of concentrating solely on development, the company strategically identifies and acquires cutting-edge healthcare technologies. This strategy, according to Xcelerate, leads to reduced expenses in product development and marketing, while also enabling faster integration into clinical practices and swifter attainment of profitability and return on investment.
In the driver’s seat of Xcelerate, you’ll find an exceptional management team with a wealth of experience and diverse expertise. Leading the pack is CEO and Director Mike O’Shea, a certified financial investigator and forensic accountant, who possesses a wealth of experience from his involvement with organizations like the US Secret Service, ATF, and other distinguished institutions. His extensive background emphasizes his in-depth comprehension of complex financial intricacies.
Joining the team as Director is Jason Householder, who also serves as the Co-Founder and CEO of Charlotte’s LenDRgroup Consulting. With over a decade devoted to healthcare banking, Jason specializes in crafting effective strategies for medical, dental, and veterinary practices. His insights help these practices navigate the complexities of business operations seamlessly.
Steve Gravely, presently the President of the Consulting Group at Jocassee, Inc., contributes significantly to the leadership. His remarkable track record includes spearheading 25 global manufacturing plants and overseeing the successful launch of over 300 new products for prominent industry giants like Michelin, AT&T, NCR, and General Motors. His expertise adds a distinctive dimension to the already extensive skill set of the management team.
Adding to this exceptional ensemble is Jon Wilken, he is a 30-year veteran of the retail food industry. He is the former President and CEO of BILO Inc., a supermarket chain which at the time of his employment was wholly owned by Ahold NV of The Netherlands. While Jon was at BILO, the company employed approximately 26,000 associates and operated over 400 retail supermarkets and convenience stores in four Southeastern States with annual sales of approximately $4.0 Billion. Since leaving Ahold/BILO in 2002 Jon has pursued entrepreneurial business ventures including partnering in a 250+ acre commercial and retail real estate planned development, The Point, in Greenville, South Carolina. The project to date has a Whole Foods supermarket, a retail shopping center, several restaurants, over 500 apartments, 8 hotels, and a 40-acre TD Bank call center campus.
Distinguished Advisory Board Members
Within Xcelerate Inc., an esteemed advisory board boasts the presence of eminent figures such as Dr. Barry Marshall, a distinguished Nobel laureate in the medical field. Alongside him stands the renowned neurosurgeon Dr. Dilan B. Ellegala, adding further depth to the board’s expertise. Also lending their insights is Dr. Anja Glisovic, a research scholar with a PhD in X Ray & Material Physics, contributing a unique perspective to the team.
In a recent addition, the advisory board extended a warm welcome to Cathy Scangarella, who currently holds the position of Chief Business Development Officer and Sector Lead for the Life Sciences at Choose New Jersey. With her involvement, the board continues to amass a wealth of industry knowledge, fortifying Xcelerate’s commitment to pioneering advancements in healthcare.
Current Ventures: Navigating Healthcare’s Frontier
Embarking on a journey through the forefront of healthcare innovation, Xcelerate Inc. is shaping the future with its dynamic and multi-faceted approach. Starting from acquiring a collection of licensed and patented intellectual property, the company’s current ventures span a diverse spectrum of groundbreaking initiatives in the medical, health, and wellness sectors.
1) Inventory of Patents Under Xcelerate Inc. Ownership and Acquisition.:
The collection includes four approved and one awaiting U.S. patents, along with two approved and one pending European patent. Additionally, the portfolio encompasses specific licensing agreements linked to research advancements from Cambridge University.
U.S. 9,889,151: Techniques for treating certain cancers using a composition that releases orthosilicic acid in the body.
U.S. 9,333,224: Methods for treating bacterial infections with a composition that releases orthosilicic acid in the body.
U.S. 10,493,097: Approaches for treating specific ulcer types (wounds) with a composition that releases orthosilicic acid in the body.
U.S. 16/089,613: Composition for bone repair or replacement containing silicate and bone/bone surrogate.
U.S. 16/670,060 (pending): Pending
EP 2211868: Silicate solution for treating melanoma
EP 3305305: Silicate solution for wound healing
EP 211782776 pending
In-licensed IP ((UK research and innovation)
Granted US, EP, AU, JP, Eurasian, CN patents in CA, HK, KR, SG
2) Development of virtual health technology to assist patients in developing countries:
Xcelerate has a strong dedication to closing the healthcare gap in developing countries, starting with a special focus on Africa. By creating virtual health technology, the company aims to make it possible for doctors to reach more people and offer medical care to those who currently have limited access.
To make this possible, Xcelerate has secured a 51% ownership in a startup medical technology and virtual health company AfiyaSasa Africa, LLC (ASA), initiated by the globally recognized Tanzanian Neurosurgeon, Dilan Ellegala. Company helps patients in developing countries talk to doctors through its platform to get the medical care they need. The ASA platform uses smart technology like AI (artificial intelligence) and AR (Augmented Reality), created by AdviNOW. This helps people who live far away from medical help and don’t have many doctors nearby, whether they’re in remote places or cities.Patients can use their cell phones, tablets, or computers to use the system. It lets doctors and medical staff assess their condition, decide the best care, and guide them through the process online. The system even has facial recognition and can remember if the patient has used it before.
The AfiyaSasa Tanzania Project is getting ready to start in various hospitals across the country with the help of its own subsidiary. Each hospital will provide special services and telehealth features as part of this project.
Back in March 2023, Xcelerate took a big step by signing an Agreement to bring its Artificial Intelligence (AI) based health services to The National Hospital of Tanzania, Muhimbili National Hospital, and Mloganzila in Dar es Salaam. This is the largest hospital in East Africa. The Muhimbili National Hospital System is the premier tertiary care hospital system for all of Tanzania, a country with 64 million people. It has around 1,500 beds for patients and serves about 2,000 patients every day.
Just two weeks later, Xcelerate signed another Agreement to introduce its AI-based health services to Haydom Regional Rural Referral Hospital, which is also known as Haydom Lutheran Hospital (“HLH”), in Haydom, Tanzania. HLH is a big hospital with 420 beds and it takes care of 5.7 million people in North Central Tanzania. Every year, HLH helps around 12,635 patients who stay in the hospital and supports about 103,173 patients who visit for outpatient care.
And there’s more to come – two more hospitals will be joining this important project soon.
3) Acquisition of Healthcare and Skincare Companies:
Xcelerate has initiated the establishment of its Xcelerate Brands division. The core objective of this division is to collaborate with marketing and manufacturing partners, working together to create over-the-counter healthcare products. These products draw from both Xcelerate’s existing patent portfolio and those of strategic partners.
In a recent development, Xcelerate, Inc. has successfully acquired a significant stake in ESN Group, Inc. and California Skin Research, Inc., collectively known as the “ESN Group.” This strategic move brings under Xcelerate’s umbrella a wide-ranging array of healthcare and skincare products. The acquisition encompasses the innovative Ceramedx® (www.ceramedx.com), a revolutionary plant-based ceramide therapy system specifically developed in consultation with dermatologists to address the concerns of individuals with dry and sensitive skin. Additionally, Xcelerate gains access to the offerings of Earth Science Beauty, further enhancing their portfolio of innovative skincare solutions.
Earth Science Naturals (ESN Group, Inc.), headquartered in Santa Barbara, California, is a passionate advocate for delivering natural beauty products that are both sustainable and cruelty-free. The foundation of ESN Group lies in crafting effective, clean skincare formulations derived from the Earth’s natural botanicals. ESN group claims to offer one of the most extensive ranges of fragrance-free beauty products available today. They meticulously source the purest ingredients, ensuring the utmost efficacy and top-quality outcomes.
Presently, ESN Group, Inc. manages two operational businesses generating revenue, which include:
Ceramedx, a facial cleanser specially formulated for dry, sensitive skin, features ESN’s exclusive RiceramideTR-3. This innovative product harnesses ESN’s natural ceramide technology. (www.ceramedx.com)
Earth Science Beauty (www.earthsciencebeauty.com) provides a range of plant-based solutions designed for skin, body, and hair care needs.
In addition to this acquisition, Xcelerate also entered into a strategic marketing agreement with ProductSector, LLC and its collaborator company, CCI Vegas. This company is an expert in brand development, particularly within the health and wellness sector. They have been working together with the management team from ESN to expand mass merchant outlets and government agencies.
Strategic Future Plans
These future plans are a testament to Xcelerate’s unwavering dedication to advancing healthcare on multiple fronts. The company’s vision extends beyond the present, encompassing breakthroughs in medical technology, virtual health solutions, and even skincare innovations. By embracing the power of technology and collaboration, Xcelerate aims to address critical healthcare challenges, bridge gaps in medical access, and provide solutions that cater to both physical well-being and self-care. Through these strategic endeavors, Xcelerate is poised to shape a more inclusive and progressive future for healthcare.Xcelerate’s plans go beyond just changing healthcare – they could also lead to more earnings. By offering a mix of medical technology, virtual health, and skincare products, the company is setting itself up to make money from different sources. This smart approach could help Xcelerate grow financially while also making a positive impact on healthcare overall.One of the notable aspects of Xcelerate’s journey is its plan for uplisting to the Nasdaq. The company’s progression from being a Pink Current to OTCQB-listed entity reflects its commitment to transparency and growth. A potential uplisting could offer greater visibility, credibility, and access to a broader investor base. This transition will undoubtedly be closely monitored by investors and market analysts for its implications on the company’s valuation and future prospects.
Corporate Information
Xcelerate holds OTCQB status as indicated on otcmarkets.com under the symbol XCRT.
As of August 15th, 2023, Xcelerate, Inc. presents a well-defined share structure that sheds light on its market dynamics. The company’s authorized shares total 1,000,000,000, while the outstanding shares in circulation amount to 406,446,072. Among these, a float of 113,254,437 shares is available for trading on the market, with the remaining 269,291,635 shares designated as restricted. Company holds a market capitalization of $33,328,578 as of August 15th, 2023
Conclusion
In the world of penny stocks, Xcelerate, Inc. (OTC: XCRT) has emerged as a standout Healthcare Services stock in 2023. Under the leadership of CEO and Director Mike O’Shea, the company has achieved remarkable progress, transitioning from its initial shell status to Pink Current and eventually reaching the esteemed OTCQB tier with ambitions of listing on the New York Stock Exchange. Xcelerate’s diverse initiatives, spanning innovative medical technology, virtual health solutions, and skincare innovations, show a holistic approach to improving healthcare. With a skilled team and strategic partnerships, the company aims not only for financial growth but also to create a positive impact on healthcare. The potential move to the NYSE adds another layer of interest, hinting at exciting times ahead for investors and the industry as a whole.
XCRT - great article just out -
https://otcstockz.com/otc-stocks/in-the-world-of-penny-stocks-keep-an-eye-on-xcelerate-inc-otcmkts-xcrt-stock-as-a-leading-healthcare-services-stock-in-2023/
In the world of penny stocks, keep an eye on Xcelerate, Inc. (OTCMKTS: XCRT Stock) as a leading Healthcare Services stock in 2023.
Summary
Since March 2021, under the dynamic leadership of CEO and Director Mike O’Shea, Xcelerate Inc (OTCQB:XCRT) has achieved significant milestones. These accomplishments have driven the company’s progression from Shell status to Pink Current, and subsequently to its current OTCQB status with a future plan of uplisting to the New York Stock Exchange.(As stated in public interviews)
Xcelerate has acquired a collection of licensed and patented intellectual property. As per their latest announcement, the company has substantially expanded its patent portfolio, securing patent rights in nine more countries, which now includes the EU, Russia, and Korea.
Xcelerate has achieved noteworthy accomplishments, such as acquiring a 51% membership interest in AfiyaSasa Africa, LLC, and initiating the AfiyaSasa Africa Pilot Project in hospitals across Africa.
Recently, Xcelerate, Inc. concluded the acquisition of a majority interest in ESN Group, Inc. and California Skin Research, Inc. (collectively referred to as the “ESN Group”). This acquisition encompasses a diverse portfolio of healthcare and skincare products, including the innovative Ceramedx® (www.ceramedx.com), the first natural plant-based ceramide therapy system designed in consultation with dermatologists for dry, sensitive skin, as well as Earth Science Beauty (www.earthsciencebeauty.com).
About Xcelerate Inc (OTC: XCRT stock).: Pioneering the Future of Healthcare Through Innovation
In the ever-changing landscape of healthcare, there are companies that stand out not only for their vision, but also for their immense impact. Xcelerate Inc. is certainly one such company, positioned to change the medical, health, and wellness industries with a visionary business plan that covers three unique yet intertwined branches.
Driven by a strong dedication to improving healthcare, Xcelerate is on a mission that impacts people worldwide. Their unique approach involves three core businesses – medical, health and wellness, each designed to address crucial aspects of healthcare in innovative and unprecedented ways:
1. Empowering Medical Technology: A World of Possibilities
Xcelerate’s first venture revolves around the ownership and licensing of a diverse range of medical equipment, coupled with an extensive portfolio of patents, pending patents, and technology licenses. This effort makes Xcelerate a leader in medical progress, making sure that the newest and most important discoveries are used to their maximum potential, benefiting both patients and medical professionals.
2. Bridging Healthcare Gaps: Virtual Health for All
Perhaps the most ambitious of their endeavors, Xcelerate is committed to bridging the healthcare gap in developing countries, with an initial focus on Africa. Through the development of virtual health technology, the company aims to extend the reach of physicians and provide accessible medical care to underserved populations. This creative method demonstrates how Xcelerate is committed to using technology to make sure everyone around the world has the same chance for good health.
3. Beauty and Science Converge: Redefining Skincare
The company’s third endeavor focuses on the formulation, packaging, and marketing of clinically tested, over-the-counter skin care products. These products have been tested clinically to make sure they work effectively. This careful combination of science and artistic design highlights how Xcelerate is dedicated to taking care of overall well-being.
A Synergy of Expertise: The Xcelerate Management Advantage
Xcelerate’s success lies in a globally renowned team consisting of translational clinicians and engineers. Instead of concentrating solely on development, the company strategically identifies and acquires cutting-edge healthcare technologies. This strategy, according to Xcelerate, leads to reduced expenses in product development and marketing, while also enabling faster integration into clinical practices and swifter attainment of profitability and return on investment.
In the driver’s seat of Xcelerate, you’ll find an exceptional management team with a wealth of experience and diverse expertise. Leading the pack is CEO and Director Mike O’Shea, a certified financial investigator and forensic accountant, who possesses a wealth of experience from his involvement with organizations like the US Secret Service, ATF, and other distinguished institutions. His extensive background emphasizes his in-depth comprehension of complex financial intricacies.
Joining the team as Director is Jason Householder, who also serves as the Co-Founder and CEO of Charlotte’s LenDRgroup Consulting. With over a decade devoted to healthcare banking, Jason specializes in crafting effective strategies for medical, dental, and veterinary practices. His insights help these practices navigate the complexities of business operations seamlessly.
Steve Gravely, presently the President of the Consulting Group at Jocassee, Inc., contributes significantly to the leadership. His remarkable track record includes spearheading 25 global manufacturing plants and overseeing the successful launch of over 300 new products for prominent industry giants like Michelin, AT&T, NCR, and General Motors. His expertise adds a distinctive dimension to the already extensive skill set of the management team.
Adding to this exceptional ensemble is Jon Wilken, he is a 30-year veteran of the retail food industry. He is the former President and CEO of BILO Inc., a supermarket chain which at the time of his employment was wholly owned by Ahold NV of The Netherlands. While Jon was at BILO, the company employed approximately 26,000 associates and operated over 400 retail supermarkets and convenience stores in four Southeastern States with annual sales of approximately $4.0 Billion. Since leaving Ahold/BILO in 2002 Jon has pursued entrepreneurial business ventures including partnering in a 250+ acre commercial and retail real estate planned development, The Point, in Greenville, South Carolina. The project to date has a Whole Foods supermarket, a retail shopping center, several restaurants, over 500 apartments, 8 hotels, and a 40-acre TD Bank call center campus.
Distinguished Advisory Board Members
Within Xcelerate Inc., an esteemed advisory board boasts the presence of eminent figures such as Dr. Barry Marshall, a distinguished Nobel laureate in the medical field. Alongside him stands the renowned neurosurgeon Dr. Dilan B. Ellegala, adding further depth to the board’s expertise. Also lending their insights is Dr. Anja Glisovic, a research scholar with a PhD in X Ray & Material Physics, contributing a unique perspective to the team.
In a recent addition, the advisory board extended a warm welcome to Cathy Scangarella, who currently holds the position of Chief Business Development Officer and Sector Lead for the Life Sciences at Choose New Jersey. With her involvement, the board continues to amass a wealth of industry knowledge, fortifying Xcelerate’s commitment to pioneering advancements in healthcare.
Current Ventures: Navigating Healthcare’s Frontier
Embarking on a journey through the forefront of healthcare innovation, Xcelerate Inc. is shaping the future with its dynamic and multi-faceted approach. Starting from acquiring a collection of licensed and patented intellectual property, the company’s current ventures span a diverse spectrum of groundbreaking initiatives in the medical, health, and wellness sectors.
1) Inventory of Patents Under Xcelerate Inc. Ownership and Acquisition.:
The collection includes four approved and one awaiting U.S. patents, along with two approved and one pending European patent. Additionally, the portfolio encompasses specific licensing agreements linked to research advancements from Cambridge University.
U.S. 9,889,151: Techniques for treating certain cancers using a composition that releases orthosilicic acid in the body.
U.S. 9,333,224: Methods for treating bacterial infections with a composition that releases orthosilicic acid in the body.
U.S. 10,493,097: Approaches for treating specific ulcer types (wounds) with a composition that releases orthosilicic acid in the body.
U.S. 16/089,613: Composition for bone repair or replacement containing silicate and bone/bone surrogate.
U.S. 16/670,060 (pending): Pending
EP 2211868: Silicate solution for treating melanoma
EP 3305305: Silicate solution for wound healing
EP 211782776 pending
In-licensed IP ((UK research and innovation)
Granted US, EP, AU, JP, Eurasian, CN patents in CA, HK, KR, SG
2) Development of virtual health technology to assist patients in developing countries:
Xcelerate has a strong dedication to closing the healthcare gap in developing countries, starting with a special focus on Africa. By creating virtual health technology, the company aims to make it possible for doctors to reach more people and offer medical care to those who currently have limited access.
To make this possible, Xcelerate has secured a 51% ownership in a startup medical technology and virtual health company AfiyaSasa Africa, LLC (ASA), initiated by the globally recognized Tanzanian Neurosurgeon, Dilan Ellegala. Company helps patients in developing countries talk to doctors through its platform to get the medical care they need. The ASA platform uses smart technology like AI (artificial intelligence) and AR (Augmented Reality), created by AdviNOW. This helps people who live far away from medical help and don’t have many doctors nearby, whether they’re in remote places or cities.Patients can use their cell phones, tablets, or computers to use the system. It lets doctors and medical staff assess their condition, decide the best care, and guide them through the process online. The system even has facial recognition and can remember if the patient has used it before.
The AfiyaSasa Tanzania Project is getting ready to start in various hospitals across the country with the help of its own subsidiary. Each hospital will provide special services and telehealth features as part of this project.
Back in March 2023, Xcelerate took a big step by signing an Agreement to bring its Artificial Intelligence (AI) based health services to The National Hospital of Tanzania, Muhimbili National Hospital, and Mloganzila in Dar es Salaam. This is the largest hospital in East Africa. The Muhimbili National Hospital System is the premier tertiary care hospital system for all of Tanzania, a country with 64 million people. It has around 1,500 beds for patients and serves about 2,000 patients every day.
Just two weeks later, Xcelerate signed another Agreement to introduce its AI-based health services to Haydom Regional Rural Referral Hospital, which is also known as Haydom Lutheran Hospital (“HLH”), in Haydom, Tanzania. HLH is a big hospital with 420 beds and it takes care of 5.7 million people in North Central Tanzania. Every year, HLH helps around 12,635 patients who stay in the hospital and supports about 103,173 patients who visit for outpatient care.
And there’s more to come – two more hospitals will be joining this important project soon.
3) Acquisition of Healthcare and Skincare Companies:
Xcelerate has initiated the establishment of its Xcelerate Brands division. The core objective of this division is to collaborate with marketing and manufacturing partners, working together to create over-the-counter healthcare products. These products draw from both Xcelerate’s existing patent portfolio and those of strategic partners.
In a recent development, Xcelerate, Inc. has successfully acquired a significant stake in ESN Group, Inc. and California Skin Research, Inc., collectively known as the “ESN Group.” This strategic move brings under Xcelerate’s umbrella a wide-ranging array of healthcare and skincare products. The acquisition encompasses the innovative Ceramedx® (www.ceramedx.com), a revolutionary plant-based ceramide therapy system specifically developed in consultation with dermatologists to address the concerns of individuals with dry and sensitive skin. Additionally, Xcelerate gains access to the offerings of Earth Science Beauty, further enhancing their portfolio of innovative skincare solutions.
Earth Science Naturals (ESN Group, Inc.), headquartered in Santa Barbara, California, is a passionate advocate for delivering natural beauty products that are both sustainable and cruelty-free. The foundation of ESN Group lies in crafting effective, clean skincare formulations derived from the Earth’s natural botanicals. ESN group claims to offer one of the most extensive ranges of fragrance-free beauty products available today. They meticulously source the purest ingredients, ensuring the utmost efficacy and top-quality outcomes.
Presently, ESN Group, Inc. manages two operational businesses generating revenue, which include:
Ceramedx, a facial cleanser specially formulated for dry, sensitive skin, features ESN’s exclusive RiceramideTR-3. This innovative product harnesses ESN’s natural ceramide technology. (www.ceramedx.com)
Earth Science Beauty (www.earthsciencebeauty.com) provides a range of plant-based solutions designed for skin, body, and hair care needs.
In addition to this acquisition, Xcelerate also entered into a strategic marketing agreement with ProductSector, LLC and its collaborator company, CCI Vegas. This company is an expert in brand development, particularly within the health and wellness sector. They have been working together with the management team from ESN to expand mass merchant outlets and government agencies.
Strategic Future Plans
These future plans are a testament to Xcelerate’s unwavering dedication to advancing healthcare on multiple fronts. The company’s vision extends beyond the present, encompassing breakthroughs in medical technology, virtual health solutions, and even skincare innovations. By embracing the power of technology and collaboration, Xcelerate aims to address critical healthcare challenges, bridge gaps in medical access, and provide solutions that cater to both physical well-being and self-care. Through these strategic endeavors, Xcelerate is poised to shape a more inclusive and progressive future for healthcare.Xcelerate’s plans go beyond just changing healthcare – they could also lead to more earnings. By offering a mix of medical technology, virtual health, and skincare products, the company is setting itself up to make money from different sources. This smart approach could help Xcelerate grow financially while also making a positive impact on healthcare overall.One of the notable aspects of Xcelerate’s journey is its plan for uplisting to the Nasdaq. The company’s progression from being a Pink Current to OTCQB-listed entity reflects its commitment to transparency and growth. A potential uplisting could offer greater visibility, credibility, and access to a broader investor base. This transition will undoubtedly be closely monitored by investors and market analysts for its implications on the company’s valuation and future prospects.
Corporate Information
Xcelerate holds OTCQB status as indicated on otcmarkets.com under the symbol XCRT.
As of August 15th, 2023, Xcelerate, Inc. presents a well-defined share structure that sheds light on its market dynamics. The company’s authorized shares total 1,000,000,000, while the outstanding shares in circulation amount to 406,446,072. Among these, a float of 113,254,437 shares is available for trading on the market, with the remaining 269,291,635 shares designated as restricted. Company holds a market capitalization of $33,328,578 as of August 15th, 2023
Conclusion
In the world of penny stocks, Xcelerate, Inc. (OTC: XCRT) has emerged as a standout Healthcare Services stock in 2023. Under the leadership of CEO and Director Mike O’Shea, the company has achieved remarkable progress, transitioning from its initial shell status to Pink Current and eventually reaching the esteemed OTCQB tier with ambitions of listing on the New York Stock Exchange. Xcelerate’s diverse initiatives, spanning innovative medical technology, virtual health solutions, and skincare innovations, show a holistic approach to improving healthcare. With a skilled team and strategic partnerships, the company aims not only for financial growth but also to create a positive impact on healthcare. The potential move to the NYSE adds another layer of interest, hinting at exciting times ahead for investors and the industry as a whole.
Great article just out on XCRT -
https://otcstockz.com/otc-stocks/in-the-world-of-penny-stocks-keep-an-eye-on-xcelerate-inc-otcmkts-xcrt-stock-as-a-leading-healthcare-services-stock-in-2023/
In the world of penny stocks, keep an eye on Xcelerate, Inc. (OTCMKTS: XCRT Stock) as a leading Healthcare Services stock in 2023.
Summary
Since March 2021, under the dynamic leadership of CEO and Director Mike O’Shea, Xcelerate Inc (OTCQB:XCRT) has achieved significant milestones. These accomplishments have driven the company’s progression from Shell status to Pink Current, and subsequently to its current OTCQB status with a future plan of uplisting to the New York Stock Exchange.(As stated in public interviews)
Xcelerate has acquired a collection of licensed and patented intellectual property. As per their latest announcement, the company has substantially expanded its patent portfolio, securing patent rights in nine more countries, which now includes the EU, Russia, and Korea.
Xcelerate has achieved noteworthy accomplishments, such as acquiring a 51% membership interest in AfiyaSasa Africa, LLC, and initiating the AfiyaSasa Africa Pilot Project in hospitals across Africa.
Recently, Xcelerate, Inc. concluded the acquisition of a majority interest in ESN Group, Inc. and California Skin Research, Inc. (collectively referred to as the “ESN Group”). This acquisition encompasses a diverse portfolio of healthcare and skincare products, including the innovative Ceramedx® (www.ceramedx.com), the first natural plant-based ceramide therapy system designed in consultation with dermatologists for dry, sensitive skin, as well as Earth Science Beauty (www.earthsciencebeauty.com).
About Xcelerate Inc (OTC: XCRT stock).: Pioneering the Future of Healthcare Through Innovation
In the ever-changing landscape of healthcare, there are companies that stand out not only for their vision, but also for their immense impact. Xcelerate Inc. is certainly one such company, positioned to change the medical, health, and wellness industries with a visionary business plan that covers three unique yet intertwined branches.
Driven by a strong dedication to improving healthcare, Xcelerate is on a mission that impacts people worldwide. Their unique approach involves three core businesses – medical, health and wellness, each designed to address crucial aspects of healthcare in innovative and unprecedented ways:
1. Empowering Medical Technology: A World of Possibilities
Xcelerate’s first venture revolves around the ownership and licensing of a diverse range of medical equipment, coupled with an extensive portfolio of patents, pending patents, and technology licenses. This effort makes Xcelerate a leader in medical progress, making sure that the newest and most important discoveries are used to their maximum potential, benefiting both patients and medical professionals.
2. Bridging Healthcare Gaps: Virtual Health for All
Perhaps the most ambitious of their endeavors, Xcelerate is committed to bridging the healthcare gap in developing countries, with an initial focus on Africa. Through the development of virtual health technology, the company aims to extend the reach of physicians and provide accessible medical care to underserved populations. This creative method demonstrates how Xcelerate is committed to using technology to make sure everyone around the world has the same chance for good health.
3. Beauty and Science Converge: Redefining Skincare
The company’s third endeavor focuses on the formulation, packaging, and marketing of clinically tested, over-the-counter skin care products. These products have been tested clinically to make sure they work effectively. This careful combination of science and artistic design highlights how Xcelerate is dedicated to taking care of overall well-being.
A Synergy of Expertise: The Xcelerate Management Advantage
Xcelerate’s success lies in a globally renowned team consisting of translational clinicians and engineers. Instead of concentrating solely on development, the company strategically identifies and acquires cutting-edge healthcare technologies. This strategy, according to Xcelerate, leads to reduced expenses in product development and marketing, while also enabling faster integration into clinical practices and swifter attainment of profitability and return on investment.
In the driver’s seat of Xcelerate, you’ll find an exceptional management team with a wealth of experience and diverse expertise. Leading the pack is CEO and Director Mike O’Shea, a certified financial investigator and forensic accountant, who possesses a wealth of experience from his involvement with organizations like the US Secret Service, ATF, and other distinguished institutions. His extensive background emphasizes his in-depth comprehension of complex financial intricacies.
Joining the team as Director is Jason Householder, who also serves as the Co-Founder and CEO of Charlotte’s LenDRgroup Consulting. With over a decade devoted to healthcare banking, Jason specializes in crafting effective strategies for medical, dental, and veterinary practices. His insights help these practices navigate the complexities of business operations seamlessly.
Steve Gravely, presently the President of the Consulting Group at Jocassee, Inc., contributes significantly to the leadership. His remarkable track record includes spearheading 25 global manufacturing plants and overseeing the successful launch of over 300 new products for prominent industry giants like Michelin, AT&T, NCR, and General Motors. His expertise adds a distinctive dimension to the already extensive skill set of the management team.
Adding to this exceptional ensemble is Jon Wilken, he is a 30-year veteran of the retail food industry. He is the former President and CEO of BILO Inc., a supermarket chain which at the time of his employment was wholly owned by Ahold NV of The Netherlands. While Jon was at BILO, the company employed approximately 26,000 associates and operated over 400 retail supermarkets and convenience stores in four Southeastern States with annual sales of approximately $4.0 Billion. Since leaving Ahold/BILO in 2002 Jon has pursued entrepreneurial business ventures including partnering in a 250+ acre commercial and retail real estate planned development, The Point, in Greenville, South Carolina. The project to date has a Whole Foods supermarket, a retail shopping center, several restaurants, over 500 apartments, 8 hotels, and a 40-acre TD Bank call center campus.
Distinguished Advisory Board Members
Within Xcelerate Inc., an esteemed advisory board boasts the presence of eminent figures such as Dr. Barry Marshall, a distinguished Nobel laureate in the medical field. Alongside him stands the renowned neurosurgeon Dr. Dilan B. Ellegala, adding further depth to the board’s expertise. Also lending their insights is Dr. Anja Glisovic, a research scholar with a PhD in X Ray & Material Physics, contributing a unique perspective to the team.
In a recent addition, the advisory board extended a warm welcome to Cathy Scangarella, who currently holds the position of Chief Business Development Officer and Sector Lead for the Life Sciences at Choose New Jersey. With her involvement, the board continues to amass a wealth of industry knowledge, fortifying Xcelerate’s commitment to pioneering advancements in healthcare.
Current Ventures: Navigating Healthcare’s Frontier
Embarking on a journey through the forefront of healthcare innovation, Xcelerate Inc. is shaping the future with its dynamic and multi-faceted approach. Starting from acquiring a collection of licensed and patented intellectual property, the company’s current ventures span a diverse spectrum of groundbreaking initiatives in the medical, health, and wellness sectors.
1) Inventory of Patents Under Xcelerate Inc. Ownership and Acquisition.:
The collection includes four approved and one awaiting U.S. patents, along with two approved and one pending European patent. Additionally, the portfolio encompasses specific licensing agreements linked to research advancements from Cambridge University.
U.S. 9,889,151: Techniques for treating certain cancers using a composition that releases orthosilicic acid in the body.
U.S. 9,333,224: Methods for treating bacterial infections with a composition that releases orthosilicic acid in the body.
U.S. 10,493,097: Approaches for treating specific ulcer types (wounds) with a composition that releases orthosilicic acid in the body.
U.S. 16/089,613: Composition for bone repair or replacement containing silicate and bone/bone surrogate.
U.S. 16/670,060 (pending): Pending
EP 2211868: Silicate solution for treating melanoma
EP 3305305: Silicate solution for wound healing
EP 211782776 pending
In-licensed IP ((UK research and innovation)
Granted US, EP, AU, JP, Eurasian, CN patents in CA, HK, KR, SG
2) Development of virtual health technology to assist patients in developing countries:
Xcelerate has a strong dedication to closing the healthcare gap in developing countries, starting with a special focus on Africa. By creating virtual health technology, the company aims to make it possible for doctors to reach more people and offer medical care to those who currently have limited access.
To make this possible, Xcelerate has secured a 51% ownership in a startup medical technology and virtual health company AfiyaSasa Africa, LLC (ASA), initiated by the globally recognized Tanzanian Neurosurgeon, Dilan Ellegala. Company helps patients in developing countries talk to doctors through its platform to get the medical care they need. The ASA platform uses smart technology like AI (artificial intelligence) and AR (Augmented Reality), created by AdviNOW. This helps people who live far away from medical help and don’t have many doctors nearby, whether they’re in remote places or cities.Patients can use their cell phones, tablets, or computers to use the system. It lets doctors and medical staff assess their condition, decide the best care, and guide them through the process online. The system even has facial recognition and can remember if the patient has used it before.
The AfiyaSasa Tanzania Project is getting ready to start in various hospitals across the country with the help of its own subsidiary. Each hospital will provide special services and telehealth features as part of this project.
Back in March 2023, Xcelerate took a big step by signing an Agreement to bring its Artificial Intelligence (AI) based health services to The National Hospital of Tanzania, Muhimbili National Hospital, and Mloganzila in Dar es Salaam. This is the largest hospital in East Africa. The Muhimbili National Hospital System is the premier tertiary care hospital system for all of Tanzania, a country with 64 million people. It has around 1,500 beds for patients and serves about 2,000 patients every day.
Just two weeks later, Xcelerate signed another Agreement to introduce its AI-based health services to Haydom Regional Rural Referral Hospital, which is also known as Haydom Lutheran Hospital (“HLH”), in Haydom, Tanzania. HLH is a big hospital with 420 beds and it takes care of 5.7 million people in North Central Tanzania. Every year, HLH helps around 12,635 patients who stay in the hospital and supports about 103,173 patients who visit for outpatient care.
And there’s more to come – two more hospitals will be joining this important project soon.
3) Acquisition of Healthcare and Skincare Companies:
Xcelerate has initiated the establishment of its Xcelerate Brands division. The core objective of this division is to collaborate with marketing and manufacturing partners, working together to create over-the-counter healthcare products. These products draw from both Xcelerate’s existing patent portfolio and those of strategic partners.
In a recent development, Xcelerate, Inc. has successfully acquired a significant stake in ESN Group, Inc. and California Skin Research, Inc., collectively known as the “ESN Group.” This strategic move brings under Xcelerate’s umbrella a wide-ranging array of healthcare and skincare products. The acquisition encompasses the innovative Ceramedx® (www.ceramedx.com), a revolutionary plant-based ceramide therapy system specifically developed in consultation with dermatologists to address the concerns of individuals with dry and sensitive skin. Additionally, Xcelerate gains access to the offerings of Earth Science Beauty, further enhancing their portfolio of innovative skincare solutions.
Earth Science Naturals (ESN Group, Inc.), headquartered in Santa Barbara, California, is a passionate advocate for delivering natural beauty products that are both sustainable and cruelty-free. The foundation of ESN Group lies in crafting effective, clean skincare formulations derived from the Earth’s natural botanicals. ESN group claims to offer one of the most extensive ranges of fragrance-free beauty products available today. They meticulously source the purest ingredients, ensuring the utmost efficacy and top-quality outcomes.
Presently, ESN Group, Inc. manages two operational businesses generating revenue, which include:
Ceramedx, a facial cleanser specially formulated for dry, sensitive skin, features ESN’s exclusive RiceramideTR-3. This innovative product harnesses ESN’s natural ceramide technology. (www.ceramedx.com)
Earth Science Beauty (www.earthsciencebeauty.com) provides a range of plant-based solutions designed for skin, body, and hair care needs.
In addition to this acquisition, Xcelerate also entered into a strategic marketing agreement with ProductSector, LLC and its collaborator company, CCI Vegas. This company is an expert in brand development, particularly within the health and wellness sector. They have been working together with the management team from ESN to expand mass merchant outlets and government agencies.
Strategic Future Plans
These future plans are a testament to Xcelerate’s unwavering dedication to advancing healthcare on multiple fronts. The company’s vision extends beyond the present, encompassing breakthroughs in medical technology, virtual health solutions, and even skincare innovations. By embracing the power of technology and collaboration, Xcelerate aims to address critical healthcare challenges, bridge gaps in medical access, and provide solutions that cater to both physical well-being and self-care. Through these strategic endeavors, Xcelerate is poised to shape a more inclusive and progressive future for healthcare.Xcelerate’s plans go beyond just changing healthcare – they could also lead to more earnings. By offering a mix of medical technology, virtual health, and skincare products, the company is setting itself up to make money from different sources. This smart approach could help Xcelerate grow financially while also making a positive impact on healthcare overall.One of the notable aspects of Xcelerate’s journey is its plan for uplisting to the Nasdaq. The company’s progression from being a Pink Current to OTCQB-listed entity reflects its commitment to transparency and growth. A potential uplisting could offer greater visibility, credibility, and access to a broader investor base. This transition will undoubtedly be closely monitored by investors and market analysts for its implications on the company’s valuation and future prospects.
Corporate Information
Xcelerate holds OTCQB status as indicated on otcmarkets.com under the symbol XCRT.
As of August 15th, 2023, Xcelerate, Inc. presents a well-defined share structure that sheds light on its market dynamics. The company’s authorized shares total 1,000,000,000, while the outstanding shares in circulation amount to 406,446,072. Among these, a float of 113,254,437 shares is available for trading on the market, with the remaining 269,291,635 shares designated as restricted. Company holds a market capitalization of $33,328,578 as of August 15th, 2023
Conclusion
In the world of penny stocks, Xcelerate, Inc. (OTC: XCRT) has emerged as a standout Healthcare Services stock in 2023. Under the leadership of CEO and Director Mike O’Shea, the company has achieved remarkable progress, transitioning from its initial shell status to Pink Current and eventually reaching the esteemed OTCQB tier with ambitions of listing on the New York Stock Exchange. Xcelerate’s diverse initiatives, spanning innovative medical technology, virtual health solutions, and skincare innovations, show a holistic approach to improving healthcare. With a skilled team and strategic partnerships, the company aims not only for financial growth but also to create a positive impact on healthcare. The potential move to the NYSE adds another layer of interest, hinting at exciting times ahead for investors and the industry as a whole.
Going to have to free up some funds to add even more. Crazy cheap here. Drop is again on tiny volume which is great. Will go back up again like last time with just a little buying.
Think we get some big news/updates any day now!
Mohamed Janabi
Dr. Janabi is the Executive Director of the Jakaya Kikwete Cardiac Institute (JKCI),
Dar es Salaam Head, and Physician to former President of United Republic of Tanzania.
Dr. Janabi has a rich training history of truly global proportions. Dr. Janabi is a graduate of the Kharkov Medical Institute (Russia), Liverpool School of Tropical Medicine (England), University of Queensland Medical School (Australia), Graduate School of Medicine Osaka University Hospital (Japan), and Bergen University (Norway).
Dr. Janabi is involved in several research projects and is the principal investigator on Atrial Fibrillation study RELY (Multi national), and the Principal Investigator TB/HIV study (multi national). Dr Janabi is also the in country director for Madaktari Africa. Dr. Janabi is also the host of the East African Cardiology Conference and lead on starting the first ACC chapter in Africa.
WOW - “Once successful there, the Ministry of Health will want the system for the whole country,” Prof Janabi said.
Just found this -
From Tanzania's leading multimedia storytelling platform providing breaking news, analysis, reports and opinions from a people centered perspective.
https://thechanzo.com/2023/03/15/the-chanzo-morning-briefing-march-15-2023/
ar es Salaam. Good morning! The Chanzo is here with a rundown of major news stories reported in Tanzania on Tuesday, March 14, 2023.
MNH partners with Afya Sasa Africa as it explores AI uses in its services
Muhimbili National Hospital (MNH) has signed a deal with Afya Sasa Africa LLC, an Artificial Intelligence firm specialising in healthcare, as the national hospital is planning to apply the firm’s Artificial Intelligence (AI) based health services at its Mloganzila centre.
MNH Executive Director Prof Mohamed Janabi was quoted as saying on Tuesday that the national hospital will start with MNH Mloganzila, and then expand to MNH Upanga.
“Once successful there, the Ministry of Health will want the system for the whole country,” Prof Janabi said.
According to reports, the ensuing months will see Afya Sasa Tanzania begin execution in the following phases: assessment of IT and Electronic Medical Record (EMR) systems at MNH and Integration of Afya Sasa systems with MNH; launching of a pilot cardiac module; and expansion to all primary and speciality medical areas.
Afya Sasa Tanzania Managing Director Sri Perera said that the company leverages the power of advanced artificial intelligence to assist the clinician in the proper diagnosis, testing, and treatment to enhance the effectiveness and efficiency of clinicians while providing the patient enhanced access to state-of-the-art care in line with the goals of the Government of Tanzania.
“Afya Sasa Africa can be customized to disease prevalence by country and even to specific regions within a country and can be accessible in English and Swahili,” Perera said. “We believe Artificial Intelligence and Afya Sasa’s System can bridge the gap in unmet healthcare needs in the developing world.”
Powered by AdviNOW Medical, the Afya Sasa system has executed exclusive rights agreements for ten initial priority markets across Africa including Tanzania, Kenya, Ethiopia, Uganda, Malawi, Zambia, Ghana, Zimbabwe, Botswana, South Africa and Egypt, representing a total catchment of 1 billion people.
And he 100% part of the XCRT team.
Anyone selling or not loading down here is making a huge mistake imo!!!
XCRT will be trading on the NASDAQ a lot quicker than most think imo - all of the pieces are lining up for them to apply very soon.
Have been looking up everything and forgot about the Advinow connection so yes - very glad you brought that up. I am a DD hound so digging like crazy now.
Dr. Ellegala founded a virtual health company recently acquired by AdviNOW, LLC which applies artificial intelligence to healthcare
https://afrikanheroes.com/tag/dilan-ellegala/
So the connection and relationship is HUGE!
Boom - and here is the connection between XCRT, Dr. Ellegala and Advinow -
https://www.prnewswire.com/news-releases/dilantha-b-ellegala-md-faans-joins-the-newly-created-advisory-board-of-xcelerate-inc-301223474.html
Dilantha B. Ellegala, MD, FAANS Joins the Newly Created Advisory Board of Xcelerate, Inc.
NEWS PROVIDED BY
Xcelerate, Inc.
08 Feb, 2021, 08:30 ET
SHARE THIS ARTICLE
MAULDIN, S.C., Feb. 8, 2021 /PRNewswire/ -- Xcelerate, Inc. (OTC: UDHI) is pleased to announce that Dr. Dilan Ellegala has accepted an invitation to join its Advisory Board, effective immediately. A University of Virginia trained neurosurgeon and former Harvard Clinical Instructor, Dr. Ellegala is an academician, medical inventor, and entrepreneur, with in-depth knowledge of med-tech commercialization.
Dr. Ellegala has been at the forefront of clinical care and medical technology development for two decades. An honors graduate of the University of Washington School of Medicine, he served academic leadership roles as Director of Neurotrauma and Cerebrovascular Neurosurgery at major universities, a founding Dean for Global Health, and has had collaborations with the Wellman Center for Photomedicine at MIT/Harvard, Clemson Bioengineering, and private industry. He has authored over 50 peer reviewed research publications and holds multiple patent claims in ultrasound technology. Dr. Ellegala has successfully commercialized medical technology and applied it to advance clinical care. He has founded several successful medical companies including Sonospine LLC, a pioneer in ultrasonic spine surgery, and a virtual health company recently acquired by AdviNOW, LLC which applies artificial intelligence to healthcare.
Dr. Ellegala has received numerous academic and clinical honors and has been consistently recognized for his excellence in patient care. In addition to his pioneering work in the US, he is a testament to the transformational power of teaching and the ever-present potential for change in the world, as demonstrated through his training of health care workers in remote Tanzania to perform brain and spine surgery. His groundbreaking work in global medical education is documented in the book, "A Surgeon in the Village: An American Doctor Teaches Brain Surgery in Africa", which was written by Pulitzer-nominated journalist Tony Bartleme. NBC's Tom Brokaw described the work as "A lyrical, inspirational and altogether rewarding account of first- and third-world surgeons working together to perform neurosurgery miracles in the heart of Africa."
"This is truly a great day for Xcelerate," said Michael O'Shea, Xcelerate's CEO. "Adding a world class surgeon and medical technology innovator with incredible business savvy and people skills to our Advisory Board is exactly what we've been seeking to transition to our next phase of business development. Dr. Ellegala is a true humanitarian who is blessed with an abundance of innate goodness. I am honored to have him join our team and look forward to utilizing all of his extraordinary talents and abilities to aide us in our ongoing acquisition and product development efforts."
https://www.aztechcouncil.org/advinow-bringing-better-medical-access-to-arizonans-through-technology/
James Bates moved to Arizona in 2012, where he ran a $700 million business for Freescale Semiconductor, a Texas-based corporation that was later acquired by NXP Semiconductors.
After the acquisition, Bates was looking for a new opportunity — a friend suggested investing in a chain of urgent care centers in the Valley.
“I knew absolutely nothing about urgent care,” Bates recalled. “Digging into the financial analysis, I quickly came to the conclusion that running a medical practice is very tough business.”
Urgent care centers see high fixed costs — providers, facilities, equipment and regulatory requirements are all expensive.
Bates almost gave up on the investment opportunity, but then he had an idea: What if you take the autonomous technology in self-driving vehicles today and use it to automate the intake and administration for urgent care centers?
“We make the doctor still responsible, but we automate everything around the doctor,” Bates said. “We built that financial model with the tech implemented, and it actually reduced the cost of running the clinic by over 70 percent. It was so dramatic that I figured I had no choice but to found the company.”
Bates filed 12 patents and founded the “world’s first fully-automated medical visit.”
It fundamentally revolutionizes health care,” said Bates, who serves as CEO of AdviNOW Medical. “This invention alone saves Medicare, it enables access for every single person on the planet, and this is how you resolve the disaster of health care that we have in this country as well as the world — this technology.
One of the greatest costs in health care today is the fact that people are using the hospital emergency room for their primary care, he said.
“Ultimately, what happens is that people who are on Medicare or Medicaid end up using the most expensive point of care, which is the emergency room, for things that they shouldn’t,” Bates said. “When you look at that scenario, the reality is the emergency room is not convenient. No one wants to use the emergency room, but they don’t really know how, or they don’t have access to a simpler and lower-cost point of care.”
The other problem is that people often forget or neglect to manage medications properly when treating chronic conditions. Patients need a follow-up system to help them help themselves, Bates said.
“You need to have primary care service that is cheap; you need to have nurse call centers which are cheap and plentiful,” he said. “Both of those things don’t exist today; it’s impossible for that to happen. What AdviNOW Medical does is it actually allows existing doctors to see three- to four-times more patients per day than they see today.”
At the same time, patient compliance — making sure patients follow through with their treatment plans — is all managed through AdviNOW Medical’s Virtual Provider Assistant, Hannah, which completely automates the clinical visit within regulatory guidelines using Artificial Intelligence (AI) and Augmented Reality (AR).
“AdviNOW Medical does all of the triage with the AI; they do all of the follow-up with the AI; they do all of the documentation for the doctor with the AI,” Bates explained. “Because they’re only making decisions now — just like the driver only has to watch the road and touch the steering wheel in their Tesla every 30 seconds — similarly, a doctor just has to confirm what the AI is suggesting on the diagnosis, confirm what the AI is suggesting on the treatment plan, and then press, ‘I agree.’”
Now, doctors can see more patients, and patients receive follow-up, data collection and compliance, almost for free, he said.
The AI handles four main components: the intake, or introductory paperwork; dynamic patient data collection, including History of Present Illness (HPI), using the AI; patient measurement collection using AR; and documentation for the doctor, also known as SOAP (subjective, objective, assessment and plan) notes.
“Ultimately, there is no data entry at all for the provider, and there’s no data collection at all for the provider,” Bates said. “All of that is done, and the provider just reviews and says, ‘I agree,’ relays that information to the patient to make sure they’re compliant with the FDA regulatory environment that we have today.”
AdviNOW Medical currently operates 11 clinics at Safeway grocery stores in the Valley, with a contract to open 600 more in Safeway stores. The company also has two Valley locations with providers on-site, three out-of-state clinics and contracts to open 400 more locations nationwide.
“We’re really excited,” Bates said. “It’s a long road to get there, but hopefully we’ll have another billion-dollar company here in Arizona. Right now, that’s where it’s leading.”
Lol - are you thinking what I'm thinking? Thanks for reminding all of us how big the relationship with Advinow is. Revolutionizing the healthcare industry with AI - and they are at the forefront!!!
To Change the World, You Need More than the Desire to Make Money
A Slice on James Bates, CEO and Founder of AdviNOW Medical
James Bates was a retiree turned entrepreneur. Bates took an untraditional path later in his life, having devoted his professional career to the innovation of self-driving cars, he engaged with clients like Tesla, Google and General Motors until he finally retired after 25 years. Left with time on his hands, he (unlike typical retirees) started to brainstorm his next big thing. He set his sights on the healthcare system, calling it “the biggest issue of our time” and founded AdviNOW Medical in 2016. AdviNOW utilizes augmented reality and AI to allow patients to perform their own assessments, eliminating the administrative burden involved with a doctor’s visit. Cutting down on time and costs for medical professionals, the self-assessments and self-administered vitals are sent directly to a patient’s provider before they even walk into the office. In its series A round, AdviNOW has found its way into clinics across the U.S with plans underway for more expansion in the coming year.
Bates founded AdviNOW in 2016 and knew right away he needed the “best in the biz” when it came to his team. Finding a slew of fresh engineer talent in the pool of recent ASU grads, he hired a starting lineup and shifted his focus to the physicians themselves. “The biggest bonus is, we had access to every medical professional you could ever want. You know, we’re nestled between three very large hospital systems, and we created relationships in all of them: Banner Health, HonorHealth and Mayo Clinic. The learnings from those hospital systems and having access to those doctors has been tremendously valuable.”
When breaking down the financials of those in the medical field, the common understanding is that everyone working in healthcare is financially well off. Taking a deeper look into the cost structure of healthcare clinics, Bates found that not all doctors are “rolling in the dough” and that greater than 60% of clinic costs are administrative. “It’s a waste. Essentially, it’s what doctors, front office and back office staff must do, such that they get paid by the insurance companies, and they don’t get sued by their patients.” Bates understands he can never replace doctors, rather AdviNOW completes tasks that doctors and medical assistants won’t have to do. “Every doctor I’ve ever talked to has said: ‘yes, the app innovation is correct.’”
Feeling confident, with doctors backing his vision, Bates tackled a new hurdle: fundraising. “It’s [fundraising] not fun. The reality is, that was something I was not ready for.” Coming from the corporate world, fundraising capital was an entirely new challenge Bates had to face. Rather than selling ideas to CEOs and CFOs, he now pitches to investors who look for completely different things when making decisions. Getting to know his audience and how to pitch to them has been a learning curve for Bates over these past years. “Any founder that tells you fundraising is easy, is a founder that has already been through the hard times of fundraising. They’ve already had an exit and they were successful, so they have people invested in them, not in their idea.” Bates observed that once a founder gets into the rhythm of fundraising, it can be less challenging to continue that process with other businesses.
Continuing his “first-time founder” journey, Bates made a few more memorable observations, a major one being: know when to ask for help. Knowing when to look outside yourself, and to lean on a mentor or other industry leader was a thoughtful learning for Bates, and one he would share with any aspiring entrepreneur especially when it comes to money and the healthcare industry. “Know your market, how long it’s going to take and make sure you have the money to get there.” Raising money earlier on can help move along the process, and investors will likely have good insights into your business. The healthcare industry can be especially challenging to enter, due to slow adoption rates, so it helps to have more guidance navigating that process as a first-time founder. “I put the initial $2 million of seed funding into my company because I didn’t want to give away my company. But by the time we did that, when I tried to bring in people, they still wanted that large chunk. The reality is, they probably could have helped with the things that, as a first-time founder, I would have needed help with.”
Bates’ personal investment wouldn’t stop at $2 million, to date he has invested upwards of $6 million of his own money into the business. He’s consistently stayed true to his belief in his idea even when faced with difficult times like COVID-19. Bates’ large clients put AdviNOW on hold, clinics closed, and revenue dried up. In fall 2020, the tides changed for AdviNOW, clients came back asking for immediate help. “There are always challenges but as long as you know the vision is there, you find a way to survive. It really makes it worth it when it comes through.”
“To Change the World, You Need More Than The Desire to Make Money”
Founder Bio
James Bates has a background in electrical and electronics engineering and has devoted himself to revolutionizing the traditional medical visit through AI and AR. He currently serves as Founder, CEO and Chairman of AdviNow Medical in Scottsdale, Arizona. Connect with Bates on LinkedIn.